Most promising biochemical test for sarcopenia:D3-creatine dilution
CSTR:
Author:
Affiliation:

(1. Faculty of Clinical Medicine, North Sichuan Medical College, Nanchong 637000, Sichuan Province, China;2. Department of Geriatrics, the Fifth People′s Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610000, China)

Clc Number:

Fund Project:

This work was supported by the Project of Scientific Research of Sichuan Health and Family Planning Commission (17PJ434).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Sarcopenia is an age-associated, progressive and generalised skeletal muscle disorder. However, almost every study about sarcopenia is concerning on measurement of lean body mass or far-free mass rather than skeletal muscle mass. Bioelectrical impedance analysis (BIA), dual energy X-ray absorptiometry (DXA), computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound examination are all commonly used methods of skeletal muscle measurement for sarcopenia, but all of them are flawed. Most of them are indirect measurement of simple indexes for anatomical skeletal muscle mass, and a few are direct measurement of index as anatomical muscle mass. D3-creatine dilution, however, is the most promising approach to directly measuring skeletal muscle mass. It provides a direct and accurate measurement of creatine pool size and skeletal muscle mass, and also can reflect skeletal muscle function. It is expected to be the most promising biochemical examination for sarcopenia, which can make up for the defects of the current common methods.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:May 03,2020
  • Revised:
  • Adopted:
  • Online: May 28,2021
  • Published:
Article QR Code